PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Return
26.45%
This Quarter Return
+7.81%
1 Year Return
+26.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$84.3B
AUM Growth
+$4.57B
(+5.7%)
Cap. Flow
-$79.4M
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,062
New
93
Increased
623
Reduced
800
Closed
105
Top Buys
| 1 |
Amazon
AMZN
|
$216M |
| 2 |
Xylem
XYL
|
$183M |
| 3 |
Agilent Technologies
A
|
$163M |
| 4 |
NVIDIA
NVDA
|
$148M |
| 5 |
Ecolab
ECL
|
$142M |
Top Sells
| 1 |
Salesforce
CRM
|
$269M |
| 2 |
Comcast
CMCSA
|
$181M |
| 3 |
Equinix
EQIX
|
$178M |
| 4 |
Wabtec
WAB
|
$166M |
| 5 |
Tesla
TSLA
|
$163M |
Sector Composition
| 1 | Technology | 29.57% |
| 2 | Healthcare | 16.47% |
| 3 | Industrials | 15.66% |
| 4 | Utilities | 8.94% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Humana
HUM
$37B
| $97.5M | 0.12% |
218,063
+8,138
| +4% | +$3.64M |
|
202
Aflac
AFL
$57.2B
| $96.9M | 0.11% |
1,388,433
+9,915
| +0.7% | +$692K |
|
203
Parker-Hannifin
PH
$96.1B
| $95.2M | 0.11% |
243,991
-3,378
| -1% | -$1.32M |
|
204
Oracle
ORCL
$654B
| $95M | 0.11% |
797,308
-33,284
| -4% | -$3.96M |
|
205
Texas Instruments
TXN
$171B
| $94.4M | 0.11% |
524,403
+22,884
| +5% | +$4.12M |
|
206
Pfizer
PFE
$141B
| $92.4M | 0.11% |
2,518,887
+103,611
| +4% | +$3.8M |
|
207
NiSource
NI
$19B
| $89.8M | 0.11% |
3,283,186
+1,833,487
| +126% | +$50.1M |
|
208
Datadog
DDOG
$47.5B
| $89.3M | 0.11% |
907,798
+819,967
| +934% | +$80.7M |
|
209
Edwards Lifesciences
EW
$47.5B
| $87.9M | 0.1% |
931,625
-62,206
| -6% | -$5.87M |
|
210
Neurocrine Biosciences
NBIX
$14.3B
| $87.2M | 0.1% |
924,416
+200,172
| +28% | +$18.9M |
|
211
Bank of America
BAC
$369B
| $87.1M | 0.1% |
3,035,894
+58,274
| +2% | +$1.67M |
|
212
S&P Global
SPGI
$164B
| $87M | 0.1% |
216,982
+48,228
| +29% | +$19.3M |
|
213
Gen Digital
GEN
$18.2B
| $85.1M | 0.1% |
4,586,621
-2,606,503
| -36% | -$48.4M |
|
214
Apellis Pharmaceuticals
APLS
$3.55B
| $84.6M | 0.1% |
928,624
+478,585
| +106% | +$43.6M |
|
|
CNH
215
CNH Industrial
CNH
$14.3B
| $84.5M | 0.1% |
5,866,376
+260,638
| +5% | +$3.75M |
|
216
American States Water
AWR
$2.88B
| $82.2M | 0.1% |
944,961
-76,049
| -7% | -$6.62M |
|
217
Rapid7
RPD
$1.32B
| $82M | 0.1% |
1,809,930
+779,412
| +76% | +$35.3M |
|
218
Ralph Lauren
RL
$18.9B
| $81.1M | 0.1% |
657,462
+389,792
| +146% | +$48.1M |
|
219
CoStar Group
CSGP
$37.9B
| $80.1M | 0.1% |
900,519
-46,313
| -5% | -$4.12M |
|
220
Welltower
WELL
$112B
| $80.1M | 0.09% |
989,667
-204,161
| -17% | -$16.5M |
|
221
Verizon
VZ
$187B
| $80M | 0.09% |
2,150,726
-107,556
| -5% | -$4M |
|
222
DexCom
DXCM
$31.6B
| $79.3M | 0.09% |
617,456
-16,459
| -3% | -$2.12M |
|
223
Elevance Health
ELV
$70.6B
| $79M | 0.09% |
177,752
+7,406
| +4% | +$3.29M |
|
224
Louisiana-Pacific
LPX
$6.9B
| $78.9M | 0.09% |
1,052,245
+320,885
| +44% | +$24.1M |
|
225
Xenon Pharmaceuticals
XENE
$3.02B
| $78.3M | 0.09% |
2,032,730
+28,433
| +1% | +$1.09M |
|